Current Health Sciences News
A collection of local, national, and international news stories highlighting the people and programs of UNLV.
How does the body react when you nix sugar from your diet? UNLV nutritionist Samantha Coogan shares a winning solution for withdrawal symptoms, and what to expect when they’re over.
After nearly losing her life in a car accident and being told she wouldn’t walk again, the public health professor is beating insurmountable odds and thriving at UNLV.
UNLV study provides an in-depth look at new fathers’ experiences with PPD.
Packing your lunch doesn’t have to stop once you grow up. UNLV nutritionist offers tips on how to pack a healthy, affordable midday meal.
UNLV nurse practitioner offers expertise after national task force releases new recommendation.
Health Sciences In The News
Dr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the Alzheimer's Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer's disease and related dementias.
The University of Nevada, Las Vegas (UNLV) has been named a National Center of Excellence for Nursing Education by the National League for Nursing (NLN) in recognition of their educational excellence and visionary leadership. The university was one of 10 programs nationwide to be named a Center of Excellence by the NLN, the leading professional organization for nurse educators.
Dr. Neal Malik reads the latest health and fitness blogs to help optimize your life. Today, Samantha Coogan — director of UNLV's Didactic Program in Nutrition & Dietetics and president of the Nevada Academy of Nutrition and Dietetics — explains how putting a halt on sweet treats affects the body.
Two weeks ago a massive heat wave struck two-thirds of the United States. It was hot enough to bake biscuits in Nebraska , cancel a triathlon in New York and knock out the power in Wisconsin. The pavement also probably burned a few people — and probably much worse than you might think.
Like humans, many bacteria like to spend time at the beach. The so-called flesh-eating bacteria, Vibrio vulnificus, don’t just like the beach; they need it, and rely on seasalt for survival. And as with human beachgoers, the warmer the water, the more of them there are.
The Cleveland Clinic’s fourth annual Alzheimer disease (AD) drug development pipeline presents a new round of clinical trials to give clinicians a comprehensive look at current research in the US. The investigators, led by Jeffrey Cummings, MD, ScD, director emeritus of Cleveland Clinic Lou Ruvo Center for Brain Health, identified all pharmacologic Alzheimer trials currently in development from Clinicaltrials.gov. They found 132 agents currently in 156 clinical trials— 28 of which are in 42 phase 3 trials; 74 in 83 phase 2 trials; and 30 in 31 phase 1 trials.